Regenerative Medicine News
Pre-transplant Umbilical Cord Blood Expansion in Lab Speeds Establishment of New Blood Supply in Patients, Reducing High-risk Time to Recovery
December 12, 2012 - (Mesoblast) - "Mesoblast's mesenchymal precursor cells are now being formally evaluated in a prospective, randomized Phase 3 trial led by Shpall in 15 centers that will compare 120 patients who receive one expanded and one regular cord blood transplant to 120 others who get the standard double cord transplant." Read Full Article
Posted on
20-Dec-12
by Toto, Brent
Tags:
Science and Industry News
Trackback Url
|
Link to this post
| Bookmark this post with:
